Skip to main content
Medeniyet Medical Journal logoLink to Medeniyet Medical Journal
letter
. 2022 Dec 28;37(4):352–353. doi: 10.4274/MMJ.galenos.2022.39024

Microcystic Elongated and Fragmented Pattern Invasion in Endometrial Cancer: Possible Prognostic Value to Precise and Individualized Therapeutic Strategies

Endometriyal Kanserde Mikrokistik Uzamış ve Parçalanmış Patern İstilası: Kesin ve Bireyselleştirilmiş Tedavi Stratejilerinin Olası Prognostik Değeri

Christos IAVAZZO 1, Alexandros FOTIOU 1, Ioannis D GKEGKES 2,*, Nikolaos VRACHNIS 3
PMCID: PMC9808849  PMID: 36578170

Dear Editor,

We read with a great deal of interest the article entitled “Prognostic Significance of Microcystic Elongated and Fragmanted (MELF) Myometrial Invasion Pattern: A Retrospective Study” by Okcu et al.1.

In their cohort, the MELF pattern was observed in 29.8% of the patients, and it was significantly related to lymphovascular space invasion (LVSI), stage, infiltrative pattern, and necrosis. No significant relation was identified with overall or disease-free survival rates. The authors concluded that additional sectioning and immunohistochemical (IHC) analysis should be performed to the excised lymph nodes to identify micrometastases as MELF associated with LVSI and lymph node metastases.

Recently, Qi et al.2 demonstrated that the combination of MELF and tumor budding is a histological marker associated with tumor aggressiveness and can be an independent predictor of adverse outcomes. Moreover, Tahara et al.3 reported a strong expression of programed death-ligand 1 (PD-L1) in the invasive front of the MELF pattern and concluded that programed cell death protein 1/PD-L1 immunotherapy demonstrated significant therapeutic effect on the management of patients with endometrial cancer and grade 1 MELF. Furthermore, Rabe et al.4 claimed that cytokeratin IHC staining could detect malignant cells in the sentinel lymph nodes of patients with endometrial cancer and MELF.

Finally, in a large cohort study, He et al.5 revealed that participants with POLE-mutated tumors and MELF pattern invasion had a 15.1-fold increase in tumor recurrence or progression risk than POLE-wild type tumors. Once again, we thank the authors for their excellent study.

Footnotes

Ethics

Peer-review: Internally peer-reviewed.

Author Contributions

Surgical and Medical Practices: C.I., A.F., I.D.G., N.V., Concept: C.I., A.F., I.D.G., Design: C.I., A.F., I.D.G., Data Collection and/or Processing: N.V., Analysis and/or Interpretation: C.I., I.D.G., N.V., Literature Search: A.F., I.D.G., Writing: C.I., I.D.G.

Conflict of Interest: The authors have no conflict of interest to declare.

Financial Disclosure: The authors declared that this study has received no financial support.

References

  • 1.Okcu O, Askan G, Sen B, Ozturk C, Duman Ozturk S, Fındık Guvendi G. Prognositc Significance of Microcystic Elongated and Fragmanted (MELF) Myometrial Invasion Pattern: A Retrospective Study. Medeni Med J. 2022;37:212–9. doi: 10.4274/MMJ.galenos.2022.40336. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Qi X, Zhu L, Zhang B. Clinicopathologic association and prognostic impact of microcystic, elongated and fragmented pattern invasion, combined with tumor budding in endometrioid endometrial cancer. J Obstet Gynaecol Res. 2022;48:2431–41. doi: 10.1111/jog.15335. [DOI] [PubMed] [Google Scholar]
  • 3.Tahara S, Kohara M, Sato K, Morii E. Strong expression of PD-L1 in invasive front of MELF pattern in endometrioid carcinoma. Pathol Res Pract. 2022;229:153699. doi: 10.1016/j.prp.2021.153699. [DOI] [PubMed] [Google Scholar]
  • 4.Rabe KM, Klein ME, Ghatak S, et al. Sentinel Nodal Metastasis Detection in Endometrial Carcinoma With Microcystic, Elongated, and Fragmented (MELF) Pattern by Cytokeratin Immunostaining. Am J Clin Pathol. 2021;156:846–52. doi: 10.1093/ajcp/aqab036. [DOI] [PubMed] [Google Scholar]
  • 5.He D, Wang H, Dong Y, et al. POLE mutation combined with microcystic, elongated and fragmented (MELF) pattern invasion in endometrial carcinomas might be associated with poor survival in Chinese women. Gynecol Oncol. 2020;159:36–42. doi: 10.1016/j.ygyno.2020.07.102. [DOI] [PubMed] [Google Scholar]

Articles from Medeniyet Medical Journal are provided here courtesy of Istanbul Medeniyet University

RESOURCES